| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,360 | $30 | $184K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,230 | $30 | $139.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 12,150 | $10 | $121.5K |
| J3262 | Injection, tocilizumab, 1 mg | 18,520 | $1 | $74.1K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 5,250 | $10 | $42K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $80 | $37.7K |
| J0897 | Injection, denosumab, 1 mg | 1,380 | $20 | $24.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $90 | $18.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 150 | $50 | $6.7K |
| 92083 | The provider may use one or more methods to determine the extent of a patient's visual field of one or both eyes; he interprets the results and prepares a report. Report this code for an extended… | 150 | $40 | $5.8K |